Daniel Kinzler

Learn More
PURPOSE Recombinant interleukin-2 (rIL-2) administration can mediate regression of solid tumors in patients with melanoma and renal cell carcinoma. A better understanding of the mechanisms of rIL-2-mediated antitumor effects has led to the investigation of novel immunotherapeutic approaches. Two approaches that appear promising include administration of(More)
This paper describes a simple method for deriving language-independent concepts by identifying groups of pages about the same topic from Wikipedias in different languages. This allows the information about a concept obtained from different Wikipedias to be merged, and by this provides a way to determine which terms from different languages refer to the same(More)
S: PLENARY and PARALLEL SESSIONS IB-IIC melanoma. This approach will capture the majority of patients with thin melanomas who are still at increased risk for nodal metastases and also significantly decrease the number of negative SLN biopsies performed in this group. Patients (n) Positive SLN (n) Percent Positive Thickness (5th AJCC) <0.75ram 34 1 i 2,9%(More)
  • 1